|
|
||||||||
RESEARCH REPORT |
1 Department of Medicine/Invärtes medicin, Helsinki University Hospital, Biomedicum Helsinki, PO Box 700 (Haartmaninkatu 8), FIN-00029 HUS, Helsinki, Finland;
2 Institute of Biomedicine/Anatomy, University of Helsinki, Helsinki, Finland;
3 Medico-social, Dental Clinic, Bogazici University, Istanbul, Turkey;
4 Department of Oral and Maxillofacial Diseases, HUCH, Institute of Dentistry, University of Helsinki, Box 41 FIN-00014 Helsinki, Finland;
5 University of Gazi, Faculty of Dentistry, Department of Periodontology, Ankara, Turkey;
6 TNO-Prevention and Health, Leiden, The Netherlands;
7 ORTON Orthopaedic Hospital of the Invalid Foundation, Helsinki, Finland; and
8 COXA Hospital for Joint Replacement, Tampere, Finland
* corresponding author, yrjo.konttinen{at}helsinki.fi
| ABSTRACT |
|---|
|
|
|---|
. However, Western blot revealed partially activated MMP-3, MMP-8, and MMP-9 in periodontitis GCF. Active MMP-8 (p < 0.05) and MMP-9 (p < 0.05) correlated with the presence of active MMP-3. It seems that resident gingival fibroblasts produce pro-MMP-3 in GCF, where it becomes activated, probably by cathepsin G or elastase released by neutrophils. Active MMP-3 then activates neutrophil-derived pro-MMP-8 and -9. Different tissue compartments/cells exert co-operative actions in mutual local MMP activation cascades.
KEY WORDS: stromelysin collagenase gelatinase periodontitis
| INTRODUCTION |
|---|
|
|
|---|
Pro-collagenase (pro-MMP-8) and pro-gelatinase (pro-MMP-9) in GCF mainly derive from fluid-phase neutrophils (Golub et al., 1995). Degranulating neutrophils activated by bacterial plaque release latent pro-enzymes (Ding et al., 1996, 1997). It is not clear how they become activated in the gingival crevice in adult periodontitis.
Stromelysin-1 (MMP-3) activates pro-MMP-8 (Ito and Nagase, 1988) and pro-MMP-9 (Ogata et al., 1992). Neutrophils do not contain stromelysin-1 (Weiss, 1989). Stromelysin-1 (MMP-3) is synthesized by fibroblasts and, to a lesser extent, by some other cells. Also, stromelysins are released as latent pro-enzymes (Okada and Nakanishi, 1989; Ingman et al., 1994, 1996). We speculated that GCF enzymes and gingival tissue stromelysin-1 may participate in reciprocal activation cascades, leading to activation of the crevicular fluid pro-collagenases and pro-gelatinases.
| MATERIALS & METHODS |
|---|
|
|
|---|
2; Löe, 1967), the plaque index (
2; Silness and Löe, 1964), and probing pocket depths (
4 mm), combined with radiographic evidence of bone loss as detected from orthopantomograms. No study subjects had received periodontal treatment or medication during the preceding 6 mos. None of the patients smoked. GCF sampling and processing were done as has been described in detail elsewhere (Tervahartiala, 2003). Although the ages between the two study groups were different, there were no significant correlations between the age and any of the MMPs studied in adult periodontitis patients or controls, or in both groups combined, indicating that age was not a confounding factor in this context.
Western Blotting
Various molecular-weight forms of MMP-3, -8, and -9 from GCF samples were analyzed by Western blotting (Ingman et al., 1994). Blots were incubated with sheep anti-human MMP-3 IgG (2 µg/mL) (Calbiochem, Oncogene Research Products, San Diego, CA, USA), or rabbit anti-human MMP-8 or MMP-9 IgG at 1:500 and 1:1000 dilutions (antibodies were provided by Dr. Jurgen Michaelis, Department of Pathology, Christchurch Medical School, New Zealand, Michaelis et al., 1990, and Dr. Lars Kjeldsen, Granulocyte Research Laboratory, University Hospital Copenhagen, Kjeldsen et al., 1993, respectively). Evaluation was performed with a Bio-Rad Model GS-700 Imaging Densitometer and Molecular Analyst/PC program (Bio-Rad, Hercules, CA, USA).
Zymography
GCF samples were analyzed for gelatinolytic activities by the use of 7.5% and 11% SDS-polyacrylamide gels containing 1 mg/mL gelatin substrate (Ding et al., 1997). The destained gels were quantified by a Bio-Rad Model GS-700 Imaging Densitometer (Bio-Rad, Hercules, CA, USA).
Immunohistochemical Staining of MMP-3 in Gingival Tissues
We stained 6-µm paraffin sections (Tervahartiala, 2003) with 2 µg/mL anti-human MMP-3 IgG (Oncogene Research Products, Calbiochem, San Diego, CA, USA).
Cell Culture
Human gingival fibroblasts isolated by the explant culture technique were maintained in RPMI-1640 containing 10% fetal calf serum and antibiotics. Confluent cells from the 47th passages were transferred to serum-free RPMI-1640 for 24 hrs before culture without or with TNF-
(10 ng/mL, R&D Systems Inc., Minneapolis, MN, USA) in serum-free media for 48 hrs. Control and conditioned media were collected.
Activity Assay for MMP-3, MMP-8, and MMP-9
MMP activities were measured by a modified pro-urokinase substrate method (Biotrak activity assay systems, Amersham Biosciences, Buckinghamshire, England) (Hanemaaijer et al., 1998). Color production was measured in a Titertek Multiscan 8-channel photometer (Flow Laboratories, Irvine, Scotland).
Statistical Analysis
Statistical calculations were made by means of a Prism data analysis program (GraphPad Software Inc., San Diego, CA, USA). We used one-way analysis of variance (ANOVA), followed by Bonferronis multiple-comparison test, to compare stimulated and non-stimulated fibroblasts. P values of less than 0.05 were considered statistically significant. The Mann-Whitney U Test was used to analyze the differences between the adult periodontitis patients and controls. Pearsons correlation test was used to assess the correlations among MMP-3, -8, -9, and their different molecular forms. Correlation between plaque index and pro/active forms of MMP-3 was done by the Pearson correlation test.
| RESULTS |
|---|
|
|
|---|
|
Immunohistochemical Staining of the Gingival Tissues
The apparent number of MMP-3-positive cells and their intensity of staining were high in adult periodontitis compared with healthy control gingiva. MMP-3 immunoreactivity was observed in fibroblast- and macrophage-like cells in gingival granulation tissue in periodontitis (Fig. 2
). There were 3.7 ± 0.7 cells per high-power field (x 400) in periodontitis (n = 7) compared with 1.3 ± 0.4 in controls (n = 5) (p = 0.0057). Controls showed negative immunoreactivity (Fig. 2
). For morphometry, we examined 5 randomly selected fields per section and analyzed 2 sections for each patient.
|
stimulation of fibroblasts (p < 0.001). MMP-8 and MMP-9 synthesis was increased (Fig. 3
significantly increased MMP-3, -8, and -9 synthesis, all MMP-3 in the stimulated fibroblast culture supernatant was in the latent pro-form, whereas MMP-8 and -9 were in their active forms (Fig. 3
|
| DISCUSSION |
|---|
|
|
|---|
Healthy gingiva contains some MMP-3, probably necessary for normal tissue remodeling, whereas MMP-3 is pathologically increased in adult periodontitis gingiva. This conclusion was confirmed in in vitro cultures. Fibroblasts increased their MMP synthesis upon stimulation with TNF-
, particularly that of MMP-3. TNF-
-stimulated gingival fibroblasts also produced neutrophil collagenase-2 (MMP-8), in accordance with TNF-
-stimulated synovial fibroblasts (Hanemaaijer et al., 1997). This enzyme represents, based on its 55-kDa weight, the mesenchymal isoform of MMP-8. All of the MMP-3 released into gingival fibroblast culture supernatant was in its 55-kDa latent pro-form. Since neutrophils, the major cells of the GCF in adult periodontitis, do not contain MMP-3, it can be concluded that the high GCF MMP-3 in adult periodontitis must derive from the gingival tissue compartment. Since TNF-
-stimulated gingival fibroblasts produce only the 55-kDa latent pro-enzyme MMP-3, but adult periodontitis GCF also contained proteolytically activated 40- to 45-kDa MMP-3, it can be concluded that pro-MMP-3 must, after secretion, undergo proteolytic conversion from its pro- to the corresponding active form. This may partly relate to TIMPs (see Appendix).
Based on the proteolytic activation of MMP-3, MMP-8, and MMP-9, and their proteolytic degradation products in the neutrophil-rich adult periodontitis crevicular fluid, we hypothesized that gingival tissue and crevicular fluid compartments co-operate in mutual proteinase activation cascades. It was found that all MMP-3 released by the stimulated fibroblasts was in its latent form, which is compatible with our hypothesis that neutrophil enzymes like cathepsin G and elastase are needed for its activation. In contrast, some of the MMP-8 and -9 was active. This suggests auto-activation or plasmin-driven activation (Birkedal-Hansen et al., 1993). High levels of t-PA, an effective pro-MMP activator (Ueda and Matsushima, 2001), have been described in TNF-stimulated gingival fibroblasts. Adult periodontitis crevicular fluid contains elevated levels of neutrophil-derived cathepsin G (Tervahartiala et al., 1996) and elastase (Ingman et al., 1994). Cathepsin G and elastase, derived from the primary, azurophilic neutrophil granules, are able to activate pro-MMP-3 (Okada and Nakanishi, 1989; Jenne, 1994). It is therefore proposed that they activate gingival tissue fibroblast-derived pro-MMP-3 in GCF. Pro-MMP-8 and pro-MMP-9 are also released from activated, degranulating neutrophils (from secondary/specific granules; Weiss, 1989). Active MMP-3 then cleaves off the 10-kDa activation peptide blocking the active-site zinc in pro-MMP-8 and pro-MMP-9. This would guarantee co-ordinated activation of pro-collagenase-8 (MMP-8) and pro-gelatinase B (MMP-9), which exert consecutive actions upon degradation of type I collagen and gelatin, respectively. This is supported by the highly significant correlation between the presence of active MMP-3 and the degree of collagenase (MMP-8) and gelatinase (MMP-9) activation in adult periodontitis. This cascade was not activated in controls. Our results demonstrate that this mutual activation cascade between gingival tissue MMP-3 and neutrophil MMP-8 and -9 plays a role only in periodontal tissue destruction, not in normal gingival tissue remodeling, perhaps according to Fig. 4
, although the hypothesis has not been fully substantiated. MMPs are also activated by tissue kallikreins, leukocyte elastase, trypsin, and cathepsin G. We and others have shown that bovine and human trypsins are effective activators of pro-MMP-9 (Morodomi et al., 1992; Sorsa et al., 1997). Proteases from Porphyromonas gingivalis are capable of activating MMP-2 (Grayson et al., 2003). When one considers the complexity of pathogenic mechanisms associated with periodontal disease, this Fig., although probably depicting one important activation cascade, is naturally a little simplistic.
|
Non-neutrophil cells, such as gingival and periodontal ligament fibroblasts, release MMP-8, whereas monocytes and macrophages form a potentially important source of MMP-9 (Page, 1991; Birkedal-Hansen et al., 1993).
The proposed role of MMP-3 is emphasized by two findings. Fibroblast-mediated synthesis of MMP-3 was stimulated with TNF-
, indicating this as a key process in gingival soft tissue inflammation. Second, somewhat surprisingly, the largest difference between healthy controls and periodontitis patients was seen not in levels of collagenase-2 (MMP-8) or gelatinase B (MMP-9), but in stromelysin-1 (MMP-3). This further indicates that "ignition", i.e., the potential to activate pro-collagenases and pro-gelatinases, is the key. This mutual activation cascade (Fig. 4
) is based on cooperative actions between not only gingival tissues and crevicular fluid, but also between fibroblasts and neutrophils, and between serine proteinases and MMPs. This may be important to prevent inadvertent and potentially harmful accidental activation of potent collagenolytic MMP machinery, which occurs only when all the circumstances for mutual and reciprocal co-operation are fulfilled.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Received November 28, 2004; Last revision September 12, 2005; Accepted September 29, 2005
| REFERENCES |
|---|
|
|
|---|
Ding Y, Uitto VJ, Haapasalo M, Lounatmaa K, Konttinen YT, Salo T, et al. (1996). Membrane components of Treponema denticola trigger proteinase release from human polymorphonuclear leukocytes. J Dent Res 75:19861993.
Ding Y, Haapasalo M, Kerosuo E, Lounatmaa K, Kotiranta A, Sorsa T (1997). Release and activation of human neutrophil matrix metallo- and serine proteinases during phagocytosis of Fusobacterium nucleatum, Porphyromonas gingivalis and Treponema denticola. J Clin Periodontol 24:237248.[ISI][Medline]
Golub LM, Sorsa T, Lee HM, Ciancio S, Sorbi D, Ramamurthy NS, et al. (1995). Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 22:100109.[ISI][Medline]
Grayson R, Douglas CW, Heath J, Rawlinson A, Evans GS (2003). Activation of human matrix metalloproteinase 2 by gingival crevicular fluid and Porphyromonas gingivalis. J Clin Periodontol 30:542550.[ISI][Medline]
Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, et al. (1997). Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 272:3150431509.
Hanemaaijer R, Visser H, Konttinen YT, Koolwijk P, Verheijen JH (1998). A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögrens syndrome contain increased latent and active gelatinase-B levels. Matrix Biol 17:657665.[ISI][Medline]
Housley TJ, Baumann AP, Braun ID, Davis G, Seperack PK, Wilhelm SM (1993). Recombinant Chinese hamster ovary cell matrix metalloprotease-3 (MMP-3, stromelysin-1). Role of calcium in promatrix metalloprotease-3 (pro-MMP-3, prostromelysin-1) activation and thermostability of the low mass catalytic domain of MMP-3. J Biol Chem 268:44814487.
Ingman T, Sorsa T, Michaelis J, Konttinen YT (1994). Immunohistochemical study of neutrophil- and fibroblast-type collagenases and stromelysin-1 in adult periodontitis. Scand J Dent Res 102:342349.[ISI][Medline]
Ingman T, Tervahartiala T, Ding Y, Tschesche H, Haerian A, Kinane DF, et al. (1996). Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 23:11271132.[ISI][Medline]
Ito A, Nagase H (1988). Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys 267:211216.[ISI][Medline]
Jenne DE (1994). Structure of the azurocidin, proteinase 3, and neutrophil elastase genes. Implications for inflammation and vasculitis. Am J Respir Crit Care Med 150(6 Pt 2):S147S154.[ISI][Medline]
Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N (1993). Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268:1042510432.
Lee W, Aitken S, Sodek J, McCulloch CA (1995). Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodontal Res 30:2333.[ISI][Medline]
Löe H (1967). The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol 38(Suppl):610616.
Michaelis J, Vissers MC, Winterbourn CC (1990). Human neutrophil collagenase cleaves alpha 1-antitrypsin. Biochem J 270:809814.[ISI][Medline]
Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H (1992). Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J 15(Pt 2):603611.
Nagase H, Suzuki K, Cawston TE, Brew K (1997). Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1). Biochem J 325(Pt 1):163167.
Ogata Y, Enghild JJ, Nagase H (1992). Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267:35813584.
Okada Y, Nakanishi I (1989). Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (gelatinase) by human neutrophil elastase and cathepsin G. FEBS Lett 249:353356.[ISI][Medline]
Okada Y, Nagase H, Harris ED Jr (1987). Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints. J Rheumatol 14(Spec No):4142.
Overall CM (1994). Regulation of tissue inhibitor of matrix metalloproteinase expression. Ann NY Acad Sci 732:5164.[ISI][Medline]
Page RC (1991). The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 26(3 Pt 2):230242.[ISI][Medline]
Silness J, Löe H (1964). Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22:121135.[Medline]
Sorsa T, Salo T, Koivunen E, Tyynelä J, Konttinen YT, Bergmann U, et al. (1997). Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem 272:2106721074.
Tervahartiala T (2003). Tumor necrosis factor-alfa and matrix metalloproteinases in human periodontal tissue destruction (dissertation). Helsinki, Finland: Univ. of Helsinki.
Tervahartiala T, Konttinen YT, Ingman T, Häyrinen-Immonen R, Ding Y, Sorsa T (1996). Cathepsin G in gingival tissue and crevicular fluid in adult periodontitis. J Clin Periodontol 23:6875.[ISI][Medline]
Ueda L, Matsushima K (2001). Stimulation of plasminogen activator activity and matrix metalloproteinases of human dental pulp-derived cells by tumor necrosis factor-alpha. J Endod 27:175179.[ISI][Medline]
Ward RV, Atkinson SJ, Slocombe PM, Docherty AJ, Reynolds JJ, Murphy G (1991). Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim Biophys Acta 1079:242246.[Medline]
Weiss SJ (1989). Tissue destruction by neutrophils. N Engl J Med 320:365376.[ISI][Medline]
This article has been cited by other articles:
![]() |
A. Beklen, M. Ainola, M. Hukkanen, C. Gurgan, T. Sorsa, and Y.T. Konttinen MMPs, IL-1, and TNF are Regulated by IL-17 in Periodontitis J. Dent. Res., April 1, 2007; 86(4): 347 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B LAMSTER and J. K AHLO Analysis of Gingival Crevicular Fluid as Applied to the Diagnosis of Oral and Systemic Diseases Ann. N.Y. Acad. Sci., March 1, 2007; 1098(1): 216 - 229. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |